These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17964771)

  • 1. Maximising the highs and minimising the lows: harm reduction guidance within ecstasy distribution networks.
    Jacinto C; Duterte M; Sales P; Murphy S
    Int J Drug Policy; 2008 Oct; 19(5):393-400. PubMed ID: 17964771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What's in a label? Ecstasy sellers' perceptions of pill brands.
    Duterte M; Jacinto C; Sales P; Murphy S
    J Psychoactive Drugs; 2009 Mar; 41(1):27-37. PubMed ID: 19455907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Users' perceptions of the risks and effects of taking ecstasy (MDMA): a questionnaire study.
    Murphy PN; Wareing M; Fisk J
    J Psychopharmacol; 2006 May; 20(3):447-55. PubMed ID: 16574719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study.
    Rodgers J; Buchanan T; Pearson C; Parrott AC; Ling J; Hefferman TM; Scholey AB
    J Psychopharmacol; 2006 May; 20(3):437-46. PubMed ID: 16174668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motivations for Selling Ecstasy among Young Adults in the Electronic Dance Music Club Culture in Brazil.
    Remy LS; Buttram ME; Kurtz SP; Surratt HL; Pechansky F
    J Psychoactive Drugs; 2017; 49(5):420-426. PubMed ID: 28692339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding recreational ecstasy use in the United States: a qualitative inquiry.
    Bahora M; Sterk CE; Elifson KW
    Int J Drug Policy; 2009 Jan; 20(1):62-9. PubMed ID: 18068967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of use and harm reduction practices of ecstasy users in Australia.
    Allott K; Redman J
    Drug Alcohol Depend; 2006 Apr; 82(2):168-76. PubMed ID: 16226850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediating MDMA-related harm: preloading and post-loading among Ecstasy-using youth.
    Kelly BC
    J Psychoactive Drugs; 2009 Mar; 41(1):19-26. PubMed ID: 19455906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceived risk associated with ecstasy use: a latent class analysis approach.
    Martins SS; Carlson RG; Alexandre PK; Falck RS
    Addict Behav; 2011 May; 36(5):551-4. PubMed ID: 21296504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pills and pints: risky drinking and alcohol-related harms among regular ecstasy users in Australia.
    Kinner SA; George J; Johnston J; Dunn M; Degenhardt L
    Drug Alcohol Rev; 2012 May; 31(3):273-80. PubMed ID: 21919977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contextualising psychological distress among regular ecstasy users: the importance of sociodemographic factors and patterns of drug use.
    George J; Kinner SA; Bruno R; Degenhardt L; Dunn M
    Drug Alcohol Rev; 2010 May; 29(3):243-9. PubMed ID: 20565515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using the Theory of Planned Behavior to predict implementation of harm reduction strategies among MDMA/ecstasy users.
    Davis AK; Rosenberg H
    Psychol Addict Behav; 2016 Jun; 30(4):500-8. PubMed ID: 27322805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Rollin' on E": a qualitative analysis of ecstasy use among inner city adolescents and young adults.
    Eiserman JM; Diamond S; Schensul JJ
    J Ethn Subst Abuse; 2005; 4(2):9-38. PubMed ID: 16275633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Male and female ecstasy users: differences in patterns of use, sleep quality and mental health outcomes.
    Ogeil RP; Rajaratnam SM; Broadbear JH
    Drug Alcohol Depend; 2013 Sep; 132(1-2):223-30. PubMed ID: 23453259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. It's a rave new world: estimating the prevalence and perceived harm of ecstasy and other drug use among club rave attendees.
    Yacoubian GS; Boyle C; Harding CA; Loftus EA
    J Drug Educ; 2003; 33(2):187-96. PubMed ID: 12929709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study.
    Rodgers J; Buchanan T; Scholey AB; Heffernan TM; Ling J; Parrott AC
    J Psychopharmacol; 2003 Dec; 17(4):389-96. PubMed ID: 14870950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-esteem and HIV risk practices among young adult ecstasy users.
    Klein H; Elifson KW; Sterk CE
    J Psychoactive Drugs; 2010 Dec; 42(4):447-56. PubMed ID: 21305909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recreational ecstasy use and depression.
    Guillot C; Greenway D
    J Psychopharmacol; 2006 May; 20(3):411-6. PubMed ID: 16574715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enlightened hedonism? Independent drug checking amongst a group of ecstasy users.
    Taylor S; Ayres T; Jones E
    Int J Drug Policy; 2020 Sep; 83():102869. PubMed ID: 32702610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.